[在放射治疗后组织肺炎的消化支气管炎:系统性审查和病例报告]
Antoine Ailloud1, Mael Morfin2, Valérie Grangeon3
1Département de radiothérapie, CHU de Saint-Étienne, Saint-Priest-en-Jarez, France; Département de radiothérapie, centre hospitalier de Roanne, Roanne, France; Université de médecine Jacques-Lisfranc, Saint-Étienne, France.
概括
放射治疗后可能发生组织性肺炎 (OP),影响1.4-3%的乳腺癌患者. 关键的风险因素包括年龄,吸烟和被辐射的肺体积,其中皮质类固醇是主要治疗方法.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
背景情况:
- 组织性肺炎 (OP) 是一种具有多种触发因素的炎症性肺部疾病,包括自身免疫性疾病和胸部放射治疗等非传染性原因.
- 放射后有组织性肺炎是一个公认的临床实体,需要与其他肺病理区分开来.
研究的目的:
- 审查有关放射治疗后有组织性肺炎的文献.
- 总结其病因,临床和放射学特征以及治疗策略.
主要方法:
- 对PubMed索引的文章进行了系统审查.
- 搜索术语包括"密码性组织性肺炎"",支气管炎消灭性组织性肺炎 (BOOP) "",非异常组织性肺炎"和"辐射"",放射治疗"",乳腺癌".
主要成果:
- 确定了96篇文章,其中49篇符合选择标准.
- 在乳腺癌患者中,放射治疗后组织性肺炎的发生率小于2.9%.
- 风险因素包括年龄,吸烟和被辐射的肺体积;诊断可能发生在辐射后长达一年.
结论:
- 组织性肺炎影响1.4-3%的乳腺癌放射治疗患者.
- 年龄,吸烟和被辐射的肺体积是显著的风险因素.
- 放射治疗师的意识对于改善患者管理至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Pneumonia IV: Management
299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


